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of Daily Living (ADLs) were positively associated with more
advanced stages of neuropathy and accounted for 59.66% of
variance. Factors two (Symptoms), four (Autonomic Neuropa-
thy) and ﬁve (Small Fiber) did not show a signiﬁcant association
with neuropathy stages. Regression with all ﬁve factors had 
R-square of 0.28, replicated across both regression methods.
CONCLUSIONS: The ﬁve resulting factors from the analysis of
the German translated QOL database, matched those from the
factor analysis using the original English version of the Norfolk
QOL-DN in a European study. Two factors, Functional
Status/Large Fiber and (ADLs) were positively associated with
more advanced stages of neuropathy.
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RETINOPATHY ON QUALITY-OF-LIFE USING DATA FROM 
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OBJECTIVES: To evaluate the effect of symptoms of diabetic
peripheral neuropathy (SDPN), diabetic retinopathy (DR) and
co-morbid SDPN & DR (COMORB) on the Healthy Days Core
Module (HRQOL-4) measures of the CDC, among US adults
≥40 years old with diagnosed diabetes, using the 2001–2002
National Health and Nutrition Examination Survey (NHANES).
METHODS: Logistic and ordinary least squares (OLS) regres-
sion models were used to assess the impact of SDPN, DR and
COMORB on HRQOL-4 measures. Included in the analysis
were 429 NHANES respondents ≥40 years old classiﬁed as
having diagnosed diabetes. Model covariates included age,
gender, race, education, current smoking status, currently asth-
matic, and history of cardiovascular disease, cancer, arthritis,
COPD, hypertension and stroke. The conditions of interest were
assessed based upon respondent self-report. All estimates were
generated using Stata statistical software, and accounted for 
the complex survey design of NHANES. RESULTS: Using the
2001–2002 NHANES, we estimated that, among US adults ≥40
years old with diagnosed diabetes, those with SDPN (OR = 7.66;
95%CI = 2.90, 20.23), DR (3.43; 1.53, 7.69), and COMORB
(5.43; 2.32, 12.73) were all more likely to report that they were
currently in poor health, compared to those without the condi-
tion of interest. Additionally, OLS models suggest that those 
with SDPN had a signiﬁcantly greater number of days during the
past month in which their physical health was not good, com-
pared to those without SDPN. SDPN was also associated with a
signiﬁcantly greater number of days during the past month in
which poor physical or mental health limited usual activities.
CONCLUSION: Among US adults ≥40 years old with diagnosed
diabetes, SDPN, DR, and COMORB all appear to have a 
signiﬁcant negative effect on quality-of-life. Future therapies 
that offer relief of these conditions may have considerable
humanistic beneﬁts.
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OBJECTIVES: The quality-of-life impact of diabetic retinal
disease progression has not been studied using internationally
standardized measures. We undertook an examination of the
relationship between visual impairment, stage of diabetic
retinopathy and quality of life. METHODS: In 2003, we mailed
a questionnaire containing the EuroQol (EQ-5D) quality of life
instrument to a random sample of Kaiser Permanente members
with type-2 diabetes. Of the 2376 patients (59%) who completed
the questionnaire, 155 patients had an eye exam with an ICD-
9-CM diagnosis of nonproliferative or proliferative retinopathy
(NPDR or PDR) during the ﬁrst six-months of 2003. After visual
acuity (VA) data had been removed from the text of the elec-
tronic medical record notes, one of us (CM) staged the retinopa-
thy in these patients by applying the American Academy of
Ophthalmology’s (AAO) International Diabetic Retinopathy
Severity Scale to the notes. A different reviewer abstracted best-
corrected VA in each eye from unmasked notes. Analysis was
based on the better-seeing eye. RESULTS: We obtained complete
data for VA, EQ5D, and AAO staging in 99 eyes with better
acuity. Patients who suffered impaired visual acuity (VA <= 0/40)
reported a generally worse quality of life than patients without
impairment (VA > 20/40). For those with least severe NPDR, the
median EQ5D scores were 0.73 (25th and 75th percentile 0.62,
1.0) among those with no visual impairment, compared with
0.69 (0.69, 0.8) among those with visual impairment. For those
with the PDR, the median EQ5D scores were 0.66 (0.62, 0.80)
among those with no visual impairment, compared with 0.52
(0.13, 0.73) among those with impaired VA. Among patients
with normal visual acuity, we observed a graded negative 
relationship between diabetic retinonopathy progression (AAO
stages) and median EQ-5D scores. CONCLUSION: A generally
decreasing quality of life is observed with more impaired VA and
more severe stages of diabetic retinopathy.
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OBJECTIVES: To evaluate if diabetes knowledge is associated
with health-related quality of life (HRQoL) among English-
speaking subjects with diabetes in Singapore. METHODS:
English-speaking subjects (aged >21) with self-reported diabetes
mellitus were recruited by convenience sampling at a public event
organized by Diabetic Society of Singapore to commemorate
World Diabetes Day. Correlation between diabetes knowledge
(measured using the General Diabetes Knowledge Test (GDKT),
range 0–100) and HRQoL (measured using the Audit of 
Diabetes-dependent Quality of life (ADDQoL), range 0–100;
EQ-5D, range C0.594 to 1.00 and the SF-6D, range 0.26–1.00)
were studied using Pearson correlation coefﬁcients. The rela-
tionship between diabetes knowledge and HRQoL was studied
using three separate multiple linear regression (MLR) models
with HRQoL scores as the dependent variable and GDKT score
as an independent variable while adjusting for age, gender, eth-
nicity, education, housing type, smoking status and presence of
acute/chronic medical conditions and diabetes complications.
RESULTS: Data from 42 subjects with complete responses were
analyzed (mean (SD) age: 53.0 (9.61) years, 45.0% female,
90.0% with >six years of education, 64.3% with other chronic
medical conditions, 40.5% with diabetes complications). Mean
(SD) GDKT, ADDQoL, EQ-5D and SF-6D scores were 33.1
(3.53), 46.9 (18.56), 0.9 (0.15) and 0.8 (0.14) respectively. 
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Correlations between diabetes knowledge and ADDQoL, EQ-5D
and SF-6D scores were 0.26, 0.30 and 0.21 respectively.
Although none of the independent variables was associated 
signiﬁcantly with HRQoL scores in any MLR model (p > 0.05),
a trend of association was nevertheless observed. CONCLU-
SIONS: Our results showed diabetes knowledge to be weakly
correlated with both diabetes-speciﬁc and generic health related
quality of life. In addition, diabetes knowledge may be positively
associated with diabetes-speciﬁc HRQoL but further studies 
utilizing larger sample size are required to conﬁrm this 
observation.
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QUALITY OF LIFE (SF12), CLINICAL OUTCOMES,AND
COMORBID CONDITIONS IN PATIENTS WITH TYPE-2
DIABETES: A POPULATION STUDY
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OBJECTIVES: Conditions comorbid with diabetes could have
an impact on clinical outcomes and quality of life. This study
examines relationships between the SF12, treatment options,
clinical outcomes, and comorbid depression in Type-2 diabetes
patients. METHODS: Participants with Type-2 diabetes in a
population study at university hospital outpatient clinics com-
pleted the SF12 and the CES-D scale (16 or higher indicates
depression). Patient reported data (including self-report of
comorbidities) was collected by mail out questionnaire, and
merged with a retrospective collection of patient clinical and 
utilization data via patient’s EMR. A cover letter signed by the
patient’s provider was sent with the questionnaire. RESULTS:
Usable response rate was 47.2% (n = 412); 56.8% respondents
were female, 64.1% in 40–69 age range, 94.2% Caucasian,
47.1% on oral medications only, 32.3% oral medications and
insulin, and 13.4% on insulin only. There was no signiﬁcant dif-
ference in mean A1C between insulin only group and oral med-
ications and insulin group. SF12 Physical Component Summary
(PCS) scores were signiﬁcantly higher in the oral medications
group than in the oral medications and insulin users group (p <
0.05), while no signiﬁcant differences were found in SF12 Mental
Component Summary (MCS) scores. Both PCS and MCS scores
signiﬁcantly correlated with number of self-reported comorbidi-
ties and complications (p < 0.01), and were both also signiﬁ-
cantly lower in the depressed group (p < 0.05). There were also
no signiﬁcant differences in depression among the various treat-
ment groups, although mean CESD score was greater than 
16 for each group. Although no signiﬁcant difference in A1C
between depressed and non-depressed groups was found,
depressed patients had a signiﬁcantly greater number of compli-
cations (p < 0.05). CONCLUSIONS: A generic measure like the
SF12 was able to detect variations in quality of life among dia-
betes patients on different treatment options, and with different
level of self-reported complications and comorbidities.
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WILLINGNESS-TO-PAY FOR INHALED INSULIN—A
CANADIAN PERSPECTIVE
Sadri H
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OBJECTIVE: To assess preference and willingness-to-pay (WTP)
for inhaled insulin (INI). Various INI technologies are under
development and will be marketed soon. However, they are likely
to be substantially more expensive than subcutaneous insulin
(SCI). We previously reported Ontario diabetic patients’ WTP
for INI. Whether general public accept this increased cost and
the value that they would give to this new technology are 
important questions which can be addressed through Contingent 
Valuation (CV). METHODS: A previously validated self-
administered questionnaire was mailed to 250 Greater Toronto
Area (GTA) households, randomly chosen based on postal codes.
One hundred questionnaires were returned, of which 85 were
complete and used for analysis. Standardized information about
diabetes and its prevalence in Ontario, INI and SCI, was pro-
vided in an informative letter based on published data. Respon-
dents’ preference for INI, and socio-economic and health data
were collected. Respondent’s WTP was elicited using “payment
scale” method. The payment vehicle was out-of-pocket.
RESULTS: Respondents were 50.8 ± 12.2 years old, 45 were
male. Signiﬁcantly more respondents preferred INI (n = 81) over
SCI (n = 4, df = 1, ∏2 = 69.75, P < 0.001). The mean monthly
WTP for INI was $68.59 ± $44.65, signiﬁcantly more than the
current average SCI cost of $50 in Ontario (tdf95 = 3.83,
CI95%:$58.87–$78.07). However, signiﬁcantly less than dia-
betic patients WTP for INI ($153.70 ± $99.90, P < 0.001) that
we previously reported. WTP for INI in subgroup of respondents
with diabetes was $98.52 ± $48.57, signiﬁcantly more than 
the WTP of general public (Mann-WhitneyU = 365.0, Z = -4.0,
P < 0.001). Multiple regression analysis showed a strong associ-
ation between respondents’ income and having diabetic (self or
family member) and their WTP for INI (F = 32.07, df(4&80), P
< 0.001). Major factors inﬂuencing the respondents preference
and WTP were convenience and income. CONCLUSION: GTA
general public prefer INI over SCI and will pay signiﬁcantly more
per month than the current SCI cost. The results could be used
in a cost-beneﬁt analysis and for future policy making.
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OBJECTIVES: The purpose of this study was to evaluate the
effectiveness of a program aimed at changing physician behav-
ior in accordance with evidence-based guidelines. The program
goals were to: improve accuracy of otitis diagnosis; prescribe
antibiotics less frequently; and prescribe analgesic drops more
frequently. We examined outcome differences for patients treated
by intervention clinic providers vs. by control clinic providers.
METHODS: Ten primary care clinics in a southwestern inte-
grated delivery system were organized into matched pairs and
assigned to either control status (mailed guidelines only) or inter-
vention status (provider exposure to formal education, guideline
tools, reinforcement messages, and feedback). The impact of the
intervention on providers who participated in the intervention
was measured using claims data for patients diagnosed with
otitis media and a post-intervention provider survey. The
outcome measures were: percentage of episodes with a primary
diagnosis of either acute otitis media (AOM), or otitis media
with effusion (OME) and/or otalgia, rate of antibiotic ﬁlls for
the two diagnosis categories; and analgesic drop ﬁll rate.
RESULTS: Claims data analysis showed signiﬁcant improvement
for intervention clinic providers over control group providers 
in decreased diagnosis of AOM (94.0% pre- vs. 91.2% post-
intervention, p = 0.0231) and increased analgesic drop ﬁlls
(7.6% pre- vs. 10.4% post-intervention for AOM, 2.4% to
11.5% for OME/otalgia, p = 0.0250), but no statistical signiﬁ-
